Goodrx Holdings Stock Performance
| GDRX Stock | USD 4.64 0.10 2.11% |
Goodrx Holdings has a performance score of 2 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.16, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Goodrx Holdings will likely underperform. Goodrx Holdings right now retains a risk of 2.97%. Please check out Goodrx Holdings value at risk, as well as the relationship between the kurtosis and market facilitation index , to decide if Goodrx Holdings will be following its current trending patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Goodrx Holdings are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly strong basic indicators, Goodrx Holdings is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (2.11) | Five Day Return 6.18 | Year To Date Return 1.75 | Ten Year Return (90.81) | All Time Return (90.81) |
1 | Acquisition by Bruehlman Ronald E of 10653 shares of Goodrx Holdings subject to Rule 16b-3 | 12/31/2024 |
2 | GoodRx Unleashes GoodRx for Pets, Simplifying Access and Reducing Costs for Pet Medications | 01/07/2025 |
3 | Disposition of 89292 shares by Karsten Voermann of Goodrx Holdings subject to Rule 16b-3 | 01/08/2025 |
4 | Disposition of 2606 shares by Romin Nabiey of Goodrx Holdings subject to Rule 16b-3 | 01/15/2025 |
5 | Acquisition by Scott Wagner of 94182 shares of Goodrx Holdings subject to Rule 16b-3 | 01/21/2025 |
6 | GoodRx Shares Gap Down Time to Sell | 01/31/2025 |
7 | Insider Trading | 02/04/2025 |
8 | Disposition of 5202 shares by Romin Nabiey of Goodrx Holdings at 4.84 subject to Rule 16b-3 | 02/07/2025 |
9 | Insights Into GoodRx Q4 Wall Street Projections for Key Metrics | 02/25/2025 |
10 | GoodRx Holdings Inc Q4 2024 Everything You Need To Know Ahead Of Earnings | 02/26/2025 |
11 | GoodRx Misses Q4 Revenue Estimates | 02/27/2025 |
12 | Q4 2024 GoodRx Holdings Inc Earnings Call Transcript | 02/28/2025 |
13 | Acquisition by Wendy Barnes of 409416 shares of Goodrx Holdings subject to Rule 16b-3 | 03/03/2025 |
14 | Balanced Outlook on GoodRx Holdings Growth Potential Amidst Cautious Market Expectations - TipRanks | 03/04/2025 |
15 | Acquisition by Romin Nabiey of 76866 shares of Goodrx Holdings subject to Rule 16b-3 | 03/05/2025 |
16 | Disposition of 2233 shares by Romin Nabiey of Goodrx Holdings subject to Rule 16b-3 | 03/07/2025 |
17 | GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending | 03/10/2025 |
18 | Disposition of 64232 shares by Scott Wagner of Goodrx Holdings subject to Rule 16b-3 | 03/13/2025 |
19 | Head-To-Head Contrast GoodRx and RingCentral | 03/14/2025 |
20 | Disposition of 7000000 shares by Idea Men, Llc of Goodrx Holdings at 4.2 subject to Rule 16b-3 | 03/21/2025 |
| Begin Period Cash Flow | 672.3 M |
Goodrx |
Goodrx Holdings Relative Risk vs. Return Landscape
If you would invest 452.00 in Goodrx Holdings on December 22, 2024 and sell it today you would earn a total of 12.00 from holding Goodrx Holdings or generate 2.65% return on investment over 90 days. Goodrx Holdings is currently generating 0.0864% in daily expected returns and assumes 2.9724% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than Goodrx, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Goodrx Holdings Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Goodrx Holdings' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Goodrx Holdings, and traders can use it to determine the average amount a Goodrx Holdings' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0291
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | GDRX | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.97 actual daily | 26 74% of assets are more volatile |
Expected Return
| 0.09 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average Goodrx Holdings is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Goodrx Holdings by adding it to a well-diversified portfolio.
Goodrx Holdings Fundamentals Growth
Goodrx Stock prices reflect investors' perceptions of the future prospects and financial health of Goodrx Holdings, and Goodrx Holdings fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Goodrx Stock performance.
| Return On Equity | 0.022 | ||||
| Return On Asset | 0.0362 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 1.87 B | ||||
| Shares Outstanding | 106.74 M | ||||
| Price To Book | 2.46 X | ||||
| Price To Sales | 2.29 X | ||||
| Revenue | 792.32 M | ||||
| Gross Profit | 744.11 M | ||||
| EBITDA | 153.92 M | ||||
| Net Income | 16.39 M | ||||
| Cash And Equivalents | 728.79 M | ||||
| Cash Per Share | 1.84 X | ||||
| Total Debt | 56.68 M | ||||
| Debt To Equity | 0.89 % | ||||
| Current Ratio | 10.34 X | ||||
| Book Value Per Share | 1.89 X | ||||
| Cash Flow From Operations | 163 K | ||||
| Earnings Per Share | 0.04 X | ||||
| Market Capitalization | 1.82 B | ||||
| Total Asset | 1.39 B | ||||
| Retained Earnings | (1.44 B) | ||||
| Working Capital | 535.35 M | ||||
About Goodrx Holdings Performance
Evaluating Goodrx Holdings' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Goodrx Holdings has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Goodrx Holdings has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (74.86) | (71.11) | |
| Return On Tangible Assets | 0.02 | 0.02 | |
| Return On Capital Employed | 0.05 | 0.09 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.02 | 0.02 |
Things to note about Goodrx Holdings performance evaluation
Checking the ongoing alerts about Goodrx Holdings for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Goodrx Holdings help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Goodrx Holdings is unlikely to experience financial distress in the next 2 years | |
| About 63.0% of the company shares are owned by institutional investors | |
| Latest headline from gurufocus.com: Disposition of 7000000 shares by Idea Men, Llc of Goodrx Holdings at 4.2 subject to Rule 16b-3 |
- Analyzing Goodrx Holdings' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Goodrx Holdings' stock is overvalued or undervalued compared to its peers.
- Examining Goodrx Holdings' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Goodrx Holdings' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Goodrx Holdings' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Goodrx Holdings' stock. These opinions can provide insight into Goodrx Holdings' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.